SCHEMBL4167134

SCHEMBL4167134

COC(=O)c1sc(C)cc1N=CN(C)C

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 8/20 0.49
TSHR P16473 3/20 0.49
HTT P42858 2/20 0.49
MAPK1 P28482 3/20 0.40
SMN1; SMN2 Q16637 2/20 0.37
MAPT P10636 2/20 0.37
KDM4E B2RXH2 4/20 0.37
LMNA P02545 3/20 0.37
MAPK10 P53779 1/20 0.36
NLRP1 Q9C000 1/20 0.36
HPGD P15428 1/20 0.36
HSD17B10 Q99714 3/20 0.36
KMT2A Q03164 3/20 0.35
MEN1 O00255 1/20 0.35
CASP1 P29466 1/20 0.35
CASP7 P55210 1/20 0.35
CYP1A2 P05177 2/20 0.35
CYP2C19 P33261 2/20 0.35
GAA P10253 1/20 0.35
TP53 P04637 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4167131 1.00 ALDH1A1 (0.49) ALDH1A1TSHRHTTMAPK1SMN1; SMN2
SCHEMBL4846697 0.92 ALDH1A1 (0.44) ALDH1A1TSHRHTTMAPK1SMN1; SMN2
SCHEMBL4846705 0.92 ALDH1A1 (0.44) ALDH1A1TSHRHTTMAPK1SMN1; SMN2
SCHEMBL1531393 0.84 ALDH1A1 (0.45) ALDH1A1TSHRHTTMAPK1SMN1; SMN2
SCHEMBL1531396 0.84 ALDH1A1 (0.45) ALDH1A1TSHRHTTMAPK1SMN1; SMN2
SCHEMBL4169597 0.83 ALDH1A1 (0.44) ALDH1A1TSHRHTTMAPK1SMN1; SMN2
SCHEMBL4169599 0.83 ALDH1A1 (0.44) ALDH1A1TSHRHTTMAPK1SMN1; SMN2
SCHEMBL12374411 0.80 MAPT (0.44) ALDH1A1TSHRHTTMAPK1SMN1; SMN2
SCHEMBL4257323 0.80 ALDH1A1 (0.42) ALDH1A1TSHRHTTMAPK1SMN1; SMN2
SCHEMBL4257319 0.80 ALDH1A1 (0.42) ALDH1A1TSHRHTTMAPK1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1987042-B1 NOVEL AMINO ALCOHOL-SUBSTITUTED ARYLTHIENOPYRIMIDINONES, PROCESS FOR THEIR PREPARATION AND THEIR USE AS MEDICAMENTS SANOFI SA (FR) 2015-01-21 EP disclosed
US-8853208-B2 Amino alcohol-substituted arylthienopyrimidinones, process for their preparation and their use as medicaments SANOFI (FR) 2014-10-07 US disclosed
US-20090076002-A1 NOVEL AMINO ALCOHOL-SUBSTITUTED ARYLTHIENOPYRIMIDINONES, PROCESS FOR THEIR PREPARATION AND THEIR USE AS MEDICAMENTS SANOFI-AVENTIS (FR) 2009-03-19 US disclosed
EP-1987042-A2 NOVEL AMINO ALCOHOL-SUBSTITUTED ARYLTHIENOPYRIMIDINONES, PROCESS FOR THEIR PREPARATION AND THEIR USE AS MEDICAMENTS sanofi-aventis (FR) 2008-11-05 EP disclosed
WO-2007093365-A2 NOVEL AMINO ALCOHOL-SUBSTITUTED ARYLTHIENOPYRIMIDINONES, PROCESS FOR THEIR PREPARATION AND THEIR USE AS MEDICAMENTS SANOFI-AVENTIS (DE) 2007-08-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090076002-A1 NOVEL AMINO ALCOHOL-SUBSTITUTED ARYLTHIENOPYRIMIDINONES, PROCESS FOR THEIR PREPARATION AND THEIR USE AS MEDICAMENTS AADAT, PNMT, MCHR1 ALDH1A1 100/4885TSHR 783/4885HTT 1625/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.